STAT3 inhibition was shown to upregulate immune checkpoints such as cytotoxic T lymphocyte associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) to enhance anti-tumor immune responses [63]. This evidence concerns the gene CTLA4 and neoplasm.